In an in vitro study of urothelial carcinoma of the bladder involving treatment with rapamycin, the NBR1 gene was also found to be upregulated, and in the same report, clinical samples linked upregulation of NBR1 with higher recurrence of the disease (47). Here, NBR1 is linked to bladder transitional cell carcinoma.